| Autor: |
Lobato, Cirley Maria de Oliveira, Codes, Liana, Silva, Giovanni Faria, Souza, Aécio Flávio Meirelles, Coelho, Henrique Sérgio Moraes, Pedroso, Maria Lucia Alves, Parise, Edison Roberto, Lima, Leila Maria Soares Tojal de Barros, Borba, Luiz Augusto, Evangelista, Andreia Silva, Rezende, Rosamar Eulira Fontes, Cheinquer, Hugo, Kuniyoshi, Aline Satie Oba, Aires, Rodrigo Sebba, Quintela, Eloiza Helena Dias, Mendes, Liliana Sampaio Costa, Nascimento, Fábio Carneiro Vosqui, Medeiros Filho, José Eymard Moraes de, Ferraz, Maria Lúcia Cardoso Gomes, Abdala, Edson, Bittencourt, Paulo Lisboa, de Souza Paiva Ferreira, Adalgisa, Salcedo, Juan Miguel Villalobos, de Lucca Schiavon, Leonardo, de Almeida Lopes, Edmundo Pessoa, Pessôa, Mário Guimarães, Gonçalves, Luciana Lofêgo, Souto, Francisco José Dutra, Hyppolito, Elodie Bomfim, Pereira, Gustavo Henrique Santos, Mattos, Angelo A., de Cássia Martins Alves Silva, Rita, de Lourdes Candolo Martinelli, Ana, Ivantes, Claudia Alexandra Pontes, Mello, Carlos Eduardo Brandão, Gomide, Geisa Perez Medina, Sette Junior, Hoel, de Tarso Aparecida Pinto, Paulo, Romeiro, Fernando Gomes, de Castro Lima, José Milton, Altikes, Isaac, Lyra, André Castro, Garcia, Raquel Francine Liermann, Villela-Nogueira, Cristiane Alves, Cuminale, Renata Cruvinel Cabral, de Omena, Andrea Magalhães Agra, Schiavon, Janaina Luz Narciso, Batista, Andrea Doria, de Liz Pellegrim Sanchez Lermen, Rafaela, Coral, Gabriela Perdomo, Paraná, Raymundo, Tovo, Cristiane Valle, Terrabuio, Débora Raquel Benedita, Filgueira, Norma Arteiro, de Paula Pessoa, Francisco Sergio Rangel, de Araújo, Fernando Antônio Barreiros, Strauss, Edna, Rocha, Cristina Melo, Ferreira, Paulo Roberto Abrão, Ruffeil, Nilma Lucia Sampaio |
| Zdroj: |
Annals of Hepatology; November-December 2019, Vol. 18 Issue: 6 p849-854, 6p |
| Abstrakt: |
Direct antiviral agents (DAAs) including sofosbuvir (SOF), daclatasvir (DCV), simeprevir (SIM) and ombitasvir, paritaprevir and dasabuvir were introduced 2015 in Brazil for treatment of hepatitis C virus (HCV) infection. The aims of this study were to assess effectiveness and safety of HCV treatment with DAA in real-life world in a highly admixed population from Brazil. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
